This inventor holds 3 USPTO granted patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1984-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1985
Title: Gizella Barta Nee Szalai: Innovator in Heterocyclic Compounds
Introduction
Gizella Barta Nee Szalai is a notable inventor based in Vecses, Hungary. She has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. With a total of three patents to her name, her work has implications in pharmaceutical compositions and chemical processes.
Latest Patents
Gizella's latest patents include innovative compounds that showcase her expertise. One of her patents focuses on Azetidinone-4-carboxylate containing a protected 3-acetyl group. This invention relates to new heterocyclic compounds that contain a protected C-acetyl group. More specifically, it concerns compounds of a particular formula where R is a group suitable for the protection of amides. Another patent involves heterocyclic compounds containing an alkoxycarbonyl and a substituted methyl group. This invention outlines a process for the preparation of these compounds and their pharmaceutical applications.
Career Highlights
Gizella Barta Nee Szalai has established herself as a prominent figure in her field through her innovative research and development. Her work at Richter Gedeon Vegyeszeti Gyar Rt. has allowed her to collaborate with other experts and contribute to advancements in chemical sciences.
Collaborations
Gizella has worked alongside notable colleagues such as Karoly Lempert and Kalman Harsanyi. Their collaborative efforts have further enhanced the impact of her inventions in the industry.
Conclusion
Gizella Barta Nee Szalai is a distinguished inventor whose work in heterocyclic compounds has made a significant mark in the field of chemistry. Her patents reflect her innovative spirit and dedication to advancing pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
